Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.
Nature. 2014 Jun 12;510(7504):278-82. doi: 10.1038/nature13229. Epub 2014 Apr 23.
Nature. 2014.
PMID: 24759320
Free PMC article.
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer.
Asangani IA, Wilder-Romans K, Dommeti VL, Krishnamurthy PM, Apel IJ, Escara-Wilke J, Plymate SR, Navone NM, Wang S, Feng FY, Chinnaiyan AM.
Asangani IA, et al. Among authors: dommeti vl.
Mol Cancer Res. 2016 Apr;14(4):324-31. doi: 10.1158/1541-7786.MCR-15-0472. Epub 2016 Jan 20.
Mol Cancer Res. 2016.
PMID: 26792867
Free PMC article.
Item in Clipboard
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.
Gollavilli PN, Pawar A, Wilder-Romans K, Natesan R, Engelke CG, Dommeti VL, Krishnamurthy PM, Nallasivam A, Apel IJ, Xu T, Qin ZS, Feng FY, Asangani IA.
Gollavilli PN, et al. Among authors: dommeti vl.
Cancer Res. 2018 Aug 15;78(16):4760-4773. doi: 10.1158/0008-5472.CAN-18-0484. Epub 2018 Jun 13.
Cancer Res. 2018.
PMID: 29898995
Item in Clipboard
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.
Shankar S, Tien JC, Siebenaler RF, Chugh S, Dommeti VL, Zelenka-Wang S, Wang XM, Apel IJ, Waninger J, Eyunni S, Xu A, Mody M, Goodrum A, Zhang Y, Tesmer JJ, Mannan R, Cao X, Vats P, Pitchiaya S, Ellison SJ, Shi J, Kumar-Sinha C, Crawford HC, Chinnaiyan AM.
Shankar S, et al. Among authors: dommeti vl.
Nat Commun. 2020 Jun 4;11(1):2817. doi: 10.1038/s41467-020-16309-2.
Nat Commun. 2020.
PMID: 32499547
Free PMC article.
Item in Clipboard
AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
Tien JC, Chugh S, Goodrum AE, Cheng Y, Mannan R, Zhang Y, Wang L, Dommeti VL, Wang X, Xu A, Hon J, Kenum C, Su F, Wang R, Cao X, Shankar S, Chinnaiyan AM.
Tien JC, et al. Among authors: dommeti vl.
Proc Natl Acad Sci U S A. 2021 May 18;118(20):e2026104118. doi: 10.1073/pnas.2026104118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33972443
Free PMC article.
Item in Clipboard
Argonaute 2 modulates EGFR-RAS signaling to promote mutant HRAS and NRAS-driven malignancies.
Siebenaler RF, Chugh S, Waninger JJ, Dommeti VL, Kenum C, Mody M, Gautam A, Patel N, Chu A, Bawa P, Hon J, Smith RD, Carlson H, Cao X, Tesmer JJG, Shankar S, Chinnaiyan AM.
Siebenaler RF, et al. Among authors: dommeti vl.
PNAS Nexus. 2022 Jul 28;1(3):pgac084. doi: 10.1093/pnasnexus/pgac084. eCollection 2022 Jul.
PNAS Nexus. 2022.
PMID: 35923912
Free PMC article.
Item in Clipboard
FOXM1 is a critical driver of lung fibroblast activation and fibrogenesis.
Penke LR, Speth JM, Dommeti VL, White ES, Bergin IL, Peters-Golden M.
Penke LR, et al. Among authors: dommeti vl.
J Clin Invest. 2018 Jun 1;128(6):2389-2405. doi: 10.1172/JCI87631. Epub 2018 May 7.
J Clin Invest. 2018.
PMID: 29733296
Free PMC article.
Item in Clipboard
Cite
Cite